PFAS exposure can worsen breast cancer
NIH/Office of the Director
An NIH study found that women with high levels of two common “forever chemicals” had up to 93% higher rates of an aggressive form of breast cancer. The discovery raises concerns about the potential health effects of persistent chemicals found in everyday products.
Women with higher blood levels of two common "forever
chemicals" may face an increased risk of developing a particularly
aggressive form of breast cancer, according to new research from the National
Institutes of Health (NIH), part of the U.S. Department of Health and Human
Services (HHS).
The study identified a connection between estrogen
receptor-negative, or ER-negative, breast cancer and two widely encountered
chemicals: perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid
(PFOS). Women with greater concentrations of these substances in their blood
were more likely to develop this type of cancer. However, researchers found no
clear link between either chemical and breast cancer risk overall.
Both substances belong to a large family of per- and polyfluoroalkyl substances, commonly called PFAS. These chemicals have been used in numerous everyday consumer products and are often described as "forever chemicals" because they resist breaking down in the environment. They can also accumulate in the human body and remain there for years.
Why This Aggressive Breast Cancer Is Concerning
ER-negative breast cancer differs from more common forms of
the disease because its tumor cells lack the receptors that allow estrogen to
stimulate cancer growth. These cancers are often more aggressive and generally
have poorer outcomes than tumors that respond to estrogen.
Despite their severity, researchers still have relatively
little information about what makes someone more likely to develop ER-negative
breast cancer. The new findings suggest that exposure to certain persistent
environmental chemicals could be one contributing factor.
"Our findings, which we confirmed using a meta-analysis
of prior research, indicate that certain legacy PFAS, including PFOA and PFOS,
are associated with a higher risk of ER-negative breast cancer, a more
aggressive tumor type with few known risk factors," explained NIH Stadtman
Investigator Alexandra White, Ph.D., who led the study.
The findings were published in the Journal of Clinical
Oncology.
Higher Forever Chemical Levels Linked to Greater Cancer
Risk
To investigate the possible connection, NIH scientists and
their collaborators examined blood samples that had been collected years before
participants received a cancer diagnosis. The researchers measured
concentrations of 17 different PFAS chemicals, allowing them to compare earlier
exposure levels with subsequent breast cancer outcomes.
The results revealed substantial differences for two
chemicals. Women in the highest PFOA exposure group had a 67% higher rate of
ER-negative breast cancer than women in the lowest group. The association was
even stronger for PFOS, with the highest exposure group showing a 93% higher
rate, nearly twice that of the lowest group.
These percentages represent relative differences between
groups rather than the absolute probability that an individual woman will
develop breast cancer. The findings also establish an association, not proof
that the chemicals directly cause the disease.
The analysis used data from the Sister
Study, a major research project conducted by NIH's National Institute of
Environmental Health Sciences (NIEHS). Between 2003 and 2009, the study
enrolled 50,884 women ages 35-74 from across the United States and Puerto Rico.
All participants were free of breast cancer when they
enrolled, although each had a full or half-sister who had already been
diagnosed with the disease. For the PFAS investigation, researchers analyzed
information from 1,609 women who subsequently developed breast cancer and a
comparison group of 2,269 women.
Could Reducing PFAS Exposure Lower Cancer Risk?
Although PFAS can remain in the environment and the body for
long periods, researchers emphasize that exposure is not necessarily
unavoidable. The findings could eventually help identify new ways to reduce the
risk of aggressive breast cancer.
"These findings matter for women's health
broadly," said first author, Che-Jung Chang, Ph.D., who previously worked
as an NIH research fellow and is now a researcher at DLH, a scientific research
organization. "Although PFAS are persistent in the environment and in our
bodies, exposure to them is still potentially modifiable, meaning people can
take steps to reduce their exposure, and these findings could open new avenues
for prevention."
The researchers are also interested in understanding how
these chemicals might influence cancer development. Because the strongest
associations appeared in tumors that lack estrogen receptors, the findings
suggest that PFAS could act through biological processes unrelated to hormonal
signaling.
Potential explanations include changes in gene activity or
alterations in the immune system. However, the study did not directly
investigate these mechanisms, so their involvement remains uncertain.
Newer Forever Chemicals Raise Unanswered Questions
Although PFOA and PFOS have largely been phased out and
replaced with other PFAS compounds, measurable amounts of both substances are
still present in most people's bodies. Their persistence means that exposure to
these older chemicals remains a potential public health concern.
The researchers say additional investigations should focus
on populations with greater PFAS exposure, as well as groups that experience
higher rates of ER-negative breast cancer. Such research could help clarify the
strength of the observed associations and identify whether certain populations
face greater risks.
Scientists also need to determine whether the newer
chemicals introduced as replacements for PFOA and PFOS carry similar health
concerns.
"More research is needed, particularly evaluating the
risk of breast cancer associated with newer replacement PFAS chemicals,"
White said.
The findings add to growing questions about the long-term
health effects of forever chemicals and highlight the importance of
understanding how environmental exposures may contribute to aggressive forms of
breast cancer.
The research received support from NIEHS grants Z01ES044005;
Z1AES103332; and R01ES032831.
Journal Reference:
- Che–Jung Chang, Katherine Pullella, Alexander P. Keil, Catherine E. Mullins, Vicky C. Chang, Anna S. Young, Jenna Weil, Maria Cardelino, Justin Byun, Dean P. Jones, Xin Hu, Douglas I. Walker, Alexandra J. White. Per- and Polyfluoroalkyl Substance Exposure and Breast Cancer Incidence in the Sister Study. Journal of Clinical Oncology, 2026; DOI: 10.1200/JCO-26-00318
